A universal vaccine could offer better protection against the seasonal flu than current vaccines, which only protect against a small group of flu strains, according to researchers who developed a vaccine prototype and tested it on mice.
H1N1, H3N2 and the Yamagata and Victoria flu sub-types were protected against by the vaccine designed by Georgia State University.
The study provides important insight into the development of a universal flu vaccine, according to the senior author of the study.
The study comes two months after the National Institutes of Health announced it was beginning phase one of a clinical trial for a universal flu vaccine.
According to data from the Centers for Disease Control and Prevention, the flu vaccine may have been less effective than previously thought.
35,000,000. The number of people in the US who got the flu during the winter 2014–2018. The CDC estimated that 20,000 people died from the flu.
Many people around the world are worried about the flu. Everyone over the age of 6 months should get a flu vaccine, including young children, people with chronic medical conditions, and people who are high risk of severe illness. A weakened version of the flu virus can be used to make a vaccine. Vaccine manufacturers are often forced to guess which flu strains will be the most prevalent as they're developing the vaccine months ahead of the flu season, a strategy that doesn't always offer strong protection According to the CDC, less than half of Americans get the flu vaccine each year. A universal shot that protects against the seasonal flu has been a goal of researchers.
Why the flu vaccine doesn't work.
The universal flu vaccine is getting closer to reality.